The effects of formulation additives on the degradation of freeze-dried ribonuclease A.
The stability of a freeze-dried model protein, ribonuclease A (RNase), was investigated under accelerated storage conditions at 45 degrees C for time periods up to 60 days. Because RNase is a fairly stable molecule around pH 7, lyophilization was performed in phosphate buffers at pH 4.0 or 10.0 to accelerate degradation kinetics. Degradation was studied by measuring enzymatic activity, the concentrations of soluble monomeric RNase, soluble aggregated (polymerized) RNase, and insoluble aggregated RNase following reconstitution of the lyophilized material at different times. The presence of air in the vial headspace accelerated degradation in the solid state in all cases. When argon or nitrogen was employed in the headspace, degradation kinetics were reduced, implying that molecular oxygen was involved in the degradation process. This interpretation was supported by the observation that 0.05% (w/v) EDTA in the formulation prior to freeze-drying retarded RNase degradation dramatically. EDTA was believed to chelate cations which may have been introduced with the buffer salts in trace quantities sufficient to catalyze autoxidation reactions. Incorporation of antioxidants ascorbic acid (at pH 4.0) and POBN (a spin trap which could have functioned as an antioxidant at pH 10.0) accelerated the degradation of RNase and appeared, in both cases, to be involved in interactions with the protein molecules. Additionally, in the presence of the antioxidants RNase degradation appeared to be accelerated by light. Although there is strong support for the oxidative hypothesis, the possibility of other competing reactions cannot be discounted. These investigations demonstrate the importance of challenging the extrapolation of some of our well-established ideas concerning small molecule solution kinetics to macromolecules in the solid state.
Townsend
M W
MW
Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285.
Byron
P R
PR
DeLuca
P P
PP
D001205:Ascorbic Acid; D002021:Buffers; D004492:Edetic Acid; D004795:Enzyme Stability; D005612:Freeze Drying; D006358:Hot Temperature; D006863:Hydrogen-Ion Concentration; D009589:Nitrogen Oxides; D010592:Pharmaceutic Aids; D010710:Phosphates; D011725:Pyridines; D012259:Ribonuclease, Pancreatic / Q000187:drug effects*; D013113:Spin Labels
D002021:Buffers; D009589:Nitrogen Oxides; D010592:Pharmaceutic Aids; D010710:Phosphates; D011725:Pyridines; D013113:Spin Labels; C043438:alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone; D004492:Edetic Acid; D012259:Ribonuclease, Pancreatic; D001205:Ascorbic Acid